Diamedica Therapeutics Inc (DMAC)
SG&A Expense Growth
-6.01%
Quarterly · Period ending:
DMAC SG&A Expense Growth
Latest reported-6.01%period ending
Latest reported-6.01%period ending
DMAC Quarterly SG&A Growth (QoQ) (0.00% → -6.01%)
Latest values, visible window
High-resolution chart · PNG
DMAC sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -6.012% | |
| -0.7558% | |
| -3.1587% | |
| 18.8101% | |
| -12.1785% | |
| 27.6552% | |
| 2.5789% | |
| 11.1111% | |
| -17.1913% | |
| -4.8825% | |
| 15.1724% | |
| -14.2402% | |
| 15.5018% | |
| 11.744% | |
| 14.4489% | |
| 5.6068% | |
| -9.7951% | |
| 13.6% | |
| 26.845% | |
| -10.3391% | |
| -0.3298% | |
| 5.662% | |
| -1.1197% | |
| 4.7834% | |
| 5.0237% | |
| 8.9876% | |
| -7.2797% | |
| 20.4152% | |
| 6.5111% | |
| 66.3346% | |
| -37.0174% | |
| -0.3846% | |
| 51.4563% | |
| -32.3314% | |
| 230.6019% | |
| 23.6538% | |
| 37.3292% | |
| -26.5483% | |
| -16.9549% | |
| 20.9203% | |
| 39.1791% | |
| -28.4925% | |
| 479.4935% | |
| -73.7017% | |
| -61.496% | |
| -8.5879% | |
| 127.4129% | |
| -50.2974% | |
| -61.243% | |
| -56.3332% | |
| 1,147.2412% | |
| -51.4225% | |
| -55.3771% | |
| -55.9065% | |
| 398.099% | |
| -42.424% | |
| -0.8261% | |
| -59.4339% | |
| 228.4964% | |
| 100.5548% | |
| -0.3872% | |
| -21.7592% | |
| 8.5523% | |
| -51.3764% | |
| 134.5999% | |
| 13.7778% | |
| -17.4708% | |
| -29.548% | |
| 37.856% | |
| 82.9755% | |
| -8.3618% | |
| -27.3554% | |
| -1.2867% | |
| -71.5676% | |
| 225.6893% | |
| -69.0106% | |
| 819.7958% | |
| 2.79% | |
| 68.459% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |